A PDCA cycle-based early intensive lipid-lowering strategy improves LDL-C goal achievement and clinical outcomes after PCI in acute coronary syndrome patients

Read full text Summarise with VIRAT
Authors: Kun Zhang, Qiuxian Liu, Yanping Wang, Xinjun Zhang, Hongyuan Wang
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

AIMS: To evaluate whether a PDCA cycle-based early intensive lipid-lowering strategy could improve LDL-C goal attainment in patients with acute coronary syndrome undergoing PCI. METHODS: This retrospective, single-center cohort study enrolled 203 consecutive ACS patients undergoing PCI between January 2022 and January 2025. Patients were assigned to a control group receiving standard lipid-lowering therapy (n=101) or a PDCA intervention group (n=102) managed through a Plan-Do-Check-Act cycle-based early intensive lipid-lowering protocol. The primary endpoint was LDL-C goal attainment at 12 weeks (

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Coronary Interventions and Diagnostics Acute Myocardial Infarction Research

Publication details

Journal / source
American Journal of Translational Research
Volume
18
Issue
3
Pages
2072–2085
Publication date
1 January 2026
Language
EN